Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Holzer, P; Ahmedzai, SH; Niederle, N; Leyendecker, P; Hopp, M; Bosse, B; Spohr, I; Reimer, K.
Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.
J Opioid Manag. 2009; 5(3): 145-151. Doi: 10.5055/jom.2009.0015
PubMed FullText FullText_MUG Google Scholar

 

Führende Autor*innen der Med Uni Graz
Holzer Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Opioids are the mainstay of management for patients with cancer-related pain. Although the analgesic efficacy of opioid therapy is well documented, the recent European Pain in Cancer survey demonstrated that the management of moderate-to-severe pain in patients with cancer is far from optimal. Bowel dysfunction, and importantly constipation, is a common side effect and has a significant impact on the patient's morbidity and quality of life. Nonpharmacological strategies and laxatives are often not effective in the management of opioid-induced constipation (OIC), making it necessary to search for new strategies for the treatment of opioid-induced bowel dysfunction. One promising strategy is the prevention of OIC with peripherally acting opioid antagonists that specifically target the underlying cause of this condition, without affecting centrally mediated analgesia. In recent studies, the novel combination of prolonged-release oral oxycodone and prolonged-release oral naloxone provided effective analgesia with improved bowel function in patients suffering from severe cancer-related and noncancer-related pain. The combination has the potential to improve the quality of pain management significantly in these patients.
Find related publications in this database (using NLM MeSH Indexing)
Analgesics, Opioid - adverse effects Analgesics, Opioid - therapeutic use
Clinical Trials as Topic -
Constipation - chemically induced Constipation - prevention and control
Drug Therapy, Combination -
Humans -
Naloxone - therapeutic use
Narcotic Antagonists - therapeutic use
Neoplasms - complications
Oxycodone - adverse effects Oxycodone - therapeutic use
Pain - drug therapy Pain - etiology
Quality of Life -
Severity of Illness Index -

© Med Uni Graz Impressum